School — Medicine Startups

Investigational drug attacks synovial sarcoma, a rare type of tumor

View Content

The drug ACXT-3102 was licensed to a Washington University startup company called Accuronix Therapeutics that was co-founded by Hawkins to develop new cancer therapies.

Print Friendly, PDF & Email

Leave a Reply

Your email address will not be published. Required fields are marked *